Opposite effects of calcitriol and paricalcitol on the PTH-(1-84)/ C-large fragment ratio in patients on hemodialysis.

被引:0
作者
Faugere, MCM [1 ]
Mawad, HW [1 ]
Trueba, DM [1 ]
Friedler, RM [1 ]
Malluche, HH [1 ]
机构
[1] Univ Kentucky, Div Nephrol Bone & Mineral Metab, Lexington, KY USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:686A / 686A
页数:1
相关论文
共 44 条
[31]   Concurrent evaluation of PTH in hemodialysis patients using N-tact-IRMA and third generation Liaison 1-84 PTH (DiaSorin) [J].
Benchetrit, Sydney ;
Green, Janice ;
Bernheim, Jacques ;
Golan, Eliezer ;
Zitman-Gal, Tali .
CLINICAL BIOCHEMISTRY, 2013, 46 (4-5) :395-396
[32]   Amino terminal cleavage of PTH(1-84) to PTH(7-84) is regulated by serum calcium concentration via calcium-sensing receptor in hemodialysis patients [J].
Koshikawa, Masao ;
Nishiguchi, Kensuke ;
Yorifuji, Soshi ;
Shimazu, Keiji ;
Takaori, Koji ;
Mori, Keita ;
Eguchi, Eriko ;
Okada, Kikuo ;
Tanaka, Atsuo ;
Kuwahara, Takashi .
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2010, 14 (03) :233-238
[33]   DIFFERENT EFFECTS OF TERIPARATIDE AND PTH 1-84 ON BONE AND MINERAL METABOLISM IN PATIENTS WITH SEVERE OSTEOPOROSIS [J].
Camozzi, V. ;
Fiore, C. ;
Piccolo, M. ;
De Bastiani, R. ;
Giorgino, F. L. ;
Armanini, D. ;
Luisetto, G. .
OSTEOPOROSIS INTERNATIONAL, 2011, 22 :S646-S646
[34]   Assessment of circulating hypocalcemic PTH fragment level and 1-84 PTH in patients with primary and secondary hyperparathyroidism pre- and post-parathyroidectomy. [J].
Cantor, T ;
D'Amour, P ;
Gao, P ;
Yamashita, H .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 :687A-687A
[35]   Bone histology confirmation of ratio guidelines in 7 ESRD patients with no hyperparathyroid patient showing a 1-84 PTH (CAP)/7-84 PTH (CIP) ratio of <1.5 [J].
Cantor, T ;
Amerling, R .
CLINICAL CHEMISTRY, 2005, 51 :A237-A237
[36]   How the use of the 1-84 PTH (CAP)/7-84 PTH (CIP) ratio benefited our dialysis patients in the control of calcium x phosphate levels [J].
Cantor, T ;
Amerling, R .
CLINICAL CHEMISTRY, 2005, 51 :A235-A236
[37]   PLASMA INTACT PTH 1-84, C-TERMINAL PTH 53-84, AND BONE-HISTOLOGY IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
VONMITTELSTAEDT, G ;
ROTH, HJ ;
GRETZ, N ;
FRANK, J ;
HELLFRITSCH, U ;
WEISSBACH, S ;
STRAUCH, M .
KIDNEY INTERNATIONAL, 1984, 26 (04) :505-505
[38]   Effects of Parathyroidectomy on Plasma iPTH and (1-84) PTH Levels in Patients with Stage 5 Chronic Kidney Disease [J].
Chen Huimin ;
Cui Ying ;
Xing Changying ;
Zha Xiaoming ;
Zhang Yan ;
Wang Qingting ;
Ma Haoyang ;
Zhang Lina ;
Zeng Ming ;
Yang Guang ;
Lv Xiaolin ;
Purrunsing, Yogendranath ;
Wang Ningning .
HORMONE AND METABOLIC RESEARCH, 2018, 50 (10) :761-767
[39]   Large carboxy-terminal parathyroid hormone (PTH) fragment with a relatively longer half-life than 1-84 PTH is secreted, directly from the parathyroid gland in humans [J].
Yamashita, H ;
Gao, P ;
Cantor, T ;
Futata, T ;
Murakami, T ;
Uchino, S ;
Watanabe, S ;
Kawamoto, H ;
Fukagawa, M ;
Noguchi, S .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 149 (04) :301-306
[40]   Absence of adynamic bone disease in African-Americans with CKD Stage 5 after 3 years of vitamin D therapy guided by iPTH and the PTH-(1-84)/N-terminally truncated PTH fragments ratio [J].
Fehmi, H. ;
Osman, Y. ;
Bhat, S. ;
Nguyen, K. ;
Daramola, O. ;
Cantor, T. ;
Monier-Faugere, M. -C. ;
Yee, J. ;
Malluche, H. H. .
CLINICAL NEPHROLOGY, 2009, 71 (03) :267-275